These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32953722)
1. Prognostic values of SNAI family members in breast cancer patients. Li D; Li L; Yang W; Chen L; Chen X; Wang Q; Hao B; Jin W; Cao Y Ann Transl Med; 2020 Aug; 8(15):922. PubMed ID: 32953722 [TBL] [Abstract][Full Text] [Related]
2. Comparative genomics on SNAI1, SNAI2, and SNAI3 orthologs. Katoh M; Katoh M Oncol Rep; 2005 Oct; 14(4):1083-6. PubMed ID: 16142376 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the Effect of SNAI Family in Breast Cancer and Immune Cell. Tu Y; Fang P; Zhang L; Sun K Front Cell Dev Biol; 2022; 10():906885. PubMed ID: 35898399 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of human SNAIL3 (SNAI3) gene in silico. Katoh M; Katoh M Int J Mol Med; 2003 Mar; 11(3):383-8. PubMed ID: 12579345 [TBL] [Abstract][Full Text] [Related]
5. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells. Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782 [TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer. Gao WL; Niu L; Chen WL; Zhang YQ; Huang WH Front Genet; 2022; 13():798170. PubMed ID: 35368696 [No Abstract] [Full Text] [Related]
7. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer. Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332 [TBL] [Abstract][Full Text] [Related]
8. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation. Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X Front Immunol; 2023; 14():1074242. PubMed ID: 37122728 [TBL] [Abstract][Full Text] [Related]
9. Absence of a major role for the snai1 and snai3 genes in regulating skeletal muscle regeneration in mice. Norton CR; Chen Y; Han XH; Bradley CK; Krebs LT; Yoon JK; Gridley T PLoS Curr; 2013 Nov; 5():. PubMed ID: 24270643 [TBL] [Abstract][Full Text] [Related]
10. The snail family gene snai3 is not essential for embryogenesis in mice. Bradley CK; Norton CR; Chen Y; Han X; Booth CJ; Yoon JK; Krebs LT; Gridley T PLoS One; 2013; 8(6):e65344. PubMed ID: 23762348 [TBL] [Abstract][Full Text] [Related]
12. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer. Liu F; Wu H J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of the diagnostic and prognostic value associated with the Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer. Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Wu JR; Zhao Y; Zhou XP; Qin X Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575 [TBL] [Abstract][Full Text] [Related]
16. Prognostic values of distinct CBX family members in breast cancer. Liang YK; Lin HY; Chen CF; Zeng D Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients. Gu S; Chu C; Chen W; Ren H; Cao Y; Li X; He J; Wang Y; Jin Y; Liu X; Zou Q Int J Clin Exp Pathol; 2019; 12(6):2009-2021. PubMed ID: 31934023 [TBL] [Abstract][Full Text] [Related]
18. Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients. Abouelghar A; Hasnah R; Taouk G; Saad M; Karam M Oncotarget; 2018 Jun; 9(43):27171-27196. PubMed ID: 29930758 [TBL] [Abstract][Full Text] [Related]
19. Characterization of SUSD3 as a novel prognostic biomarker and therapeutic target for breast cancer. Dong YM; Bao GQ Clin Transl Oncol; 2024 Aug; ():. PubMed ID: 39107655 [TBL] [Abstract][Full Text] [Related]
20. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy. Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]